Literature DB >> 11444195

Early uterine serous carcinoma: clonal origin of extrauterine disease.

R N Baergen1, C D Warren, C Isacson, L H Ellenson.   

Abstract

Uterine serous carcinoma (USC) is an uncommon but aggressive type of endometrial carcinoma that is frequently associated with extrauterine disease despite minimal or no myometrial invasion. The origin of the extrauterine tumors in this setting remains controversial. The majority of USCs (90%) and endometrial intraepithelial carcinomas (78%), the putative precursor of USC, have p53 mutations, suggesting that p53 alterations occur early in the pathogenesis of USC. To determine if the extrauterine tumors associated with minimally invasive USC and endometrial intraepithelial carcinoma (EIC) represent metastases or multifocal primary tumors, we examined the mutational pattern of the p53 gene in 3 cases of minimally invasive USC and 1 case of EIC and in the corresponding extrauterine tumors associated with each of the cases. In all 4 cases, the primary tumors and the associated extrauterine tumor foci had identical p53 mutations. Our results support the premise that extrauterine serous tumors found in association with EIC or minimally invasive USC represent a unifocal process and thus are early metastases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444195     DOI: 10.1097/00004347-200107000-00002

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  19 in total

1.  Endometrial serous carcinoma (uterine papillary serous carcinoma): precancerous lesions and the theoretical promise of a preventive approach.

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

2.  Allelic loss at TP53 in metastatic human endometrial carcinomas.

Authors:  Wiktor Szewczuk; Danuta Skomra; Marek Cybulski; Dorota Przadka-Rabaniuk; Agata Filip; Maciej Jóźwik; Piotr Olcha; Albert Roessner; Andrzej Semczuk
Journal:  Clin Exp Metastasis       Date:  2009-06-30       Impact factor: 5.150

Review 3.  A guided tour of selected issues pertaining to metastatic carcinomas involving or originating from the gynecologic tract.

Authors:  Robert A Soslow; Rajmohan Murali
Journal:  Semin Diagn Pathol       Date:  2017-11-20       Impact factor: 3.464

Review 4.  Practical issues related to uterine pathology: staging, frozen section, artifacts, and Lynch syndrome.

Authors:  Robert A Soslow
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

5.  Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma.

Authors:  Lin Jia; Zeng Yuan; Yiying Wang; Janiel M Cragun; Beihua Kong; Wenxin Zheng
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

6.  Insights into endometrial serous carcinogenesis and progression.

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Int J Clin Exp Pathol       Date:  2009-01-10

7.  Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.

Authors:  Elisabetta Kuhn; Ren-Chin Wu; Bin Guan; Gang Wu; Jinghui Zhang; Yue Wang; Lei Song; Xiguo Yuan; Lei Wei; Richard B S Roden; Kuan-Tin Kuo; Kentaro Nakayama; Blaise Clarke; Patricia Shaw; Narciso Olvera; Robert J Kurman; Douglas A Levine; Tian-Li Wang; Ie-Ming Shih
Journal:  J Natl Cancer Inst       Date:  2012-08-23       Impact factor: 13.506

8.  Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice.

Authors:  Takiko Daikoku; Yasushi Hirota; Susanne Tranguch; Ayesha R Joshi; Francesco J DeMayo; John P Lydon; Lora H Ellenson; Sudhansu K Dey
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

9.  Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.

Authors:  Murray Joseph Casey; Chhanda Bewtra; Henry T Lynch; Carrie Snyder; Mark Stacy; Patrice Watson
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

10.  Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial.

Authors:  Ashley S Felix; Louise A Brinton; D Scott McMeekin; William T Creasman; David Mutch; David E Cohn; Joan L Walker; Richard G Moore; Levi S Downs; Robert A Soslow; Richard Zaino; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2015-06-18       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.